Format

Send to

Choose Destination
Lancet. 2009 Sep 19;374(9694):979-988. doi: 10.1016/S0140-6736(09)60736-4. Epub 2009 Aug 3.

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.

Author information

1
University Medical Centre, Groningen, Netherlands. Electronic address: c.m.koopmans@og.umcg.nl.
2
Academic Medical Centre, Amsterdam, Netherlands.
3
University Medical Centre, Groningen, Netherlands.
4
Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
5
Hospital Rijnstate, Arnhem, Netherlands.
6
Scheper Hospital, Emmen, Netherlands.
7
Leiden University Medical Centre, Netherlands.
8
Twee Steden Hospital, Tilburg, Netherlands.
9
Sint Elisabeth Hospital, Tilburg, Netherlands.
10
Medical Centre Haaglanden, Den Haag, Netherlands.
11
Gelre Hospital, Apeldoorn, Netherlands.
12
University Medical Centre, Utrecht, Netherlands.
13
Martini Hospital, Groningen, Netherlands.
14
Spaarne Hospital, Hoofddorp, Netherlands.
15
Amphia Hospital, Breda, Netherlands.
16
Atrium Medical Centre, Heerlen, Netherlands.
17
University Medical Centre St Radboud, Nijmegen, Netherlands.
18
University Hospital Maastricht, Netherlands.
19
Academic Medical Centre, Amsterdam, Netherlands; Maxima Medical Centre, Veldhoven, Netherlands.

Abstract

BACKGROUND:

Robust evidence to direct management of pregnant women with mild hypertensive disease at term is scarce. We investigated whether induction of labour in women with a singleton pregnancy complicated by gestational hypertension or mild pre-eclampsia reduces severe maternal morbidity.

METHODS:

We undertook a multicentre, parallel, open-label randomised controlled trial in six academic and 32 non-academic hospitals in the Netherlands between October, 2005, and March, 2008. We enrolled patients with a singleton pregnancy at 36-41 weeks' gestation, and who had gestational hypertension or mild pre-eclampsia. Participants were randomly allocated in a 1:1 ratio by block randomisation with a web-based application system to receive either induction of labour or expectant monitoring. Masking of intervention allocation was not possible. The primary outcome was a composite measure of poor maternal outcome--maternal mortality, maternal morbidity (eclampsia, HELLP syndrome, pulmonary oedema, thromboembolic disease, and placental abruption), progression to severe hypertension or proteinuria, and major post-partum haemorrhage (>1000 mL blood loss). Analysis was by intention to treat and treatment effect is presented as relative risk. This study is registered, number ISRCTN08132825.

FINDINGS:

756 patients were allocated to receive induction of labour (n=377 patients) or expectant monitoring (n=379). 397 patients refused randomisation but authorised use of their medical records. Of women who were randomised, 117 (31%) allocated to induction of labour developed poor maternal outcome compared with 166 (44%) allocated to expectant monitoring (relative risk 0.71, 95% CI 0.59-0.86, p<0.0001). No cases of maternal or neonatal death or eclampsia were recorded.

INTERPRETATION:

Induction of labour is associated with improved maternal outcome and should be advised for women with mild hypertensive disease beyond 37 weeks' gestation.

FUNDING:

ZonMw.

PMID:
19656558
DOI:
10.1016/S0140-6736(09)60736-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center